Skip to content
Topiroxostat
Topiroxostat is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target xanthine dehydrogenase/oxidase.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
2 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HyperuricemiaD03346111
Diabetic nephropathiesD003928EFO_000040111
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTOPIROXOSTAT
INNtopiroxostat
Description
Topiroxostat (INN; trade names Topiloric, Uriadec) is a drug for the treatment of gout and hyperuricemia. It was approved for use in Japan in June 2013.
Classification
Small molecule
Drug classenzyme inhibitors: xanthine oxidase/dehydrogenase inhibitors
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
N#Cc1cc(-c2n[nH]c(-c3ccncc3)n2)ccn1
Identifiers
PDB
CAS-ID577778-58-6
RxCUI
ChEMBL IDCHEMBL1078685
ChEBI ID
PubChem CID5288320
DrugBankDB01685
UNII ID0J877412JV (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
XDH
XDH
Organism
Homo sapiens
Gene name
XDH
Gene synonyms
XDHA
NCBI Gene ID
Protein name
xanthine dehydrogenase/oxidase
Protein synonyms
xanthine oxidoreductase
Uniprot ID
Mouse ortholog
Xdh (22436)
xanthine dehydrogenase/oxidase (Q00519)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 235 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details